Skip to Content
Merck
CN
All Photos(2)

Documents

700063P

Avanti

lanosterol

Avanti Polar Lipids

Sign Into View Organizational & Contract Pricing
All Photos(2)
Synonym(s):
lanosterin; lanosta-8,24-dienol
Empirical Formula (Hill Notation):
C30H50O
CAS Number:
79-63-0
Molecular Weight:
426.72
UNSPSC Code:
12352211
NACRES:
NA.25

description

8,24-lanostadien-3β-ol

Assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 mg (700063P-1mg)
pkg of 1 × 10 mg (700063P-10mg)
pkg of 1 × 5 mg (700063P-5mg)

manufacturer/tradename

Avanti Polar Lipids

shipped in

dry ice

storage temp.

−20°C

InChI

1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1

InChI key

CAHGCLMLTWQZNJ-BQNIITSRSA-N

General description

Lanosterol is a lanostane-type tetracyclic triterpene, which is the first sterol in lipid biosynthetic pathway.

Biochem/physiol Actions

Lanosterol inhibits cataract formation, prevents lens opacity and reverses crystalline aggregation.

Packaging

5 mL Amber Glass Screw Cap Vial (700063P-10mg)
5 mL Amber Glass Screw Cap Vial (700063P-1mg)
5 mL Amber Glass Screw Cap Vial (700063P-5mg)

also commonly purchased with this product

Product No.
Description
Pricing

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Lanosterol synthase pathway alleviates lens opacity in age-related cortical cataract
Shen X, et al.
Journal of Ophthalmology, 41(4), 744-747 (2018)
Tetracyclic triterpenes from Inonotus obliquus (PERS.) PIL.(CHAGA) growing in Russia
Zhukovich EN, et al.
Pharmaceutical Chemistry Journal, 2018, 495-496 (2010)
Lindsay M Webb et al.
The Journal of clinical investigation, 130(4), 1683-1698 (2020-02-25)
Protein arginine methyltransferase 5 (PRMT5) catalyzes symmetric dimethylation (SDM) of arginine, a posttranslational modification involved in oncogenesis and embryonic development. However, the role and mechanisms by which PRMT5 modulates Th cell polarization and autoimmune disease have not yet been elucidated.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service